Conversion to Resection
Intera 3000 for Patients with Unresectable Colorectal Liver Metastases (CLM)
Treatment with the Intera 3000 Pump and floxuridine combined with systemic chemotherapy can reduce tumor burden and enable previously unresectable CLM to be successfully removed. Conversion to resection is a key factor in increasing overall survival in patients with CLM.
According to a study at Memorial Sloan Kettering, 47% of patients with unresectable liver metastases who received an Intera 3000 pump with floxuridine and systemic chemotherapy were able to be surgically resected following treatment.